Pages Tagged with "Covid-19"

Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2
MEDIA CONTACTLetisia Marquez626-218-3398lemarquez@coh.orgThe investigational vaccine is now being used in Phase 2 trials for immunocompromised patients and as a booster for healthy adult volunteers. LOS...
Tips on surviving isolation from patients who have been there
With California’s safer-at-home order extended until at least May 15, many people are starting to reach their wits’ end in dealing with this unexpected social isolation. There is a group...
GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine
Contacts: Letisia Marquez City of Hope Media Relations Manager lemarquez@coh.org 626-476-7593   GeoVax Labs, Inc. investor@geovax.com 678-384-7220   Phase 2 Vaccine Designed to Enhance Response for Immunocompromised Patients Complements GeoVax’s...
TGen develops COVID-19 test
Since mid-January, the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has been part of the worldwide effort to conduct testing for the SARS-CoV-2 virus causing...
COVID-19 Vaccines and Breast Cancer Screening: What You Need to Know
Early this year, Laura Kruper, M.D., M.S., chief of the Division of Breast Surgery at City of Hope, started seeing more women whose lymph nodes looked suspiciously enlarged on routine...
City of Hope coronavirus vaccine produces strong immunity in preclinical research
A City of Hope investigational vaccine produced strong protective immunity against SARS-CoV-2, including neutralizing antibodies that recognize the current dominant circulating form, which is a mutant of the original Wuhan...
The latest COVID-19 advice for cancer patients, survivors and caregivers
A year ago, we sought advice for cancer patients, survivors and caregivers on coping with the risks from the COVID-19 pandemic from Sanjeet Dadwal, M.D., chief of City of Hope's Division...
City of Hope researchers mining database for COVID clues
James Lacey Jr., Ph.D., M.P.H. Researchers looking to control the spread of COVID-19 are working with City of Hope scientists who manage a 25-year-old landmark study originally developed to track...
Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms
John J. Rossi, Ph.D. Two existing drugs, created by a City of Hope scientist using advanced genomic technology, are being tested for their potential to fight the COVID-19 epidemic. One could be used...
City of Hope to begin CIRM-funded coronavirus study
John Zaia, M.D. The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hope’s John Zaia, M.D., for a clinical study on the use of blood plasma as a...
Subscribe to COVID-19